| P/E (FY) | — | Sales (TTM) | €262.6M |
| Earnings (TTM) | €40.2M | ROE | 42.79% |
| Net Margin | 15.31% | ROIC | 47.51% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 14.99% |
Clínica Baviera, S.A. is a medical company providing ophthalmological services in Spain, Germany, and the rest of Europe. It performs refractive, presbyopia, and cataract surgeries and treats conditions including corneal disease, dry eye, strabismus, glaucoma, and pediatric and neuro-ophthalmological disorders, alongside consultations and rehabilitation services. Formerly Clínica Oftalmológica Baviera, S.L., it was incorporated in 1992, is based in Madrid, and is a subsidiary of Aier Eye International (Europe), S.L.U.
| Market Cap | — | Trading Days | 3798 |
| 52W High | 61.80 |
| 52W Low | 40.10 |
| % Off High | −5.83% |
| YTD | 17.10% | 1Y | 36.94% |
| 3Y | 200.00% | 5Y | 315.71% |
| 10Y | 615.87% | Since incept. (ann.) | 14.11% |
| Ann. Volatility (1Y) | 27.69% | Ann. Volatility (3Y) | 28.86% |
| Sharpe (1Y) | 1.29 | Sharpe (3Y) | 1.51 |
| Max Drawdown (1Y) | −14.21% | Max Drawdown (3Y) | −21.39% |
| Beta (3Y, vs SPY) | 0.74 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| LLY | ELI LILLY & Co | $1.15T | 53.2 |
| JNJ | JOHNSON & JOHNSON | $642.79B | 24.2 |
| ONC | BeOne Medicines Ltd. | $477.60B | 1739.3 |
| ABBV | AbbVie Inc. | $465.02B | 111.5 |
| MRK | Merck & Co., Inc. | $325.57B | 18.1 |
| AMGN | AMGEN INC | $212.16B | 27.6 |
| ABT | ABBOTT LABORATORIES | $186.84B | 28.8 |
| GILD | GILEAD SCIENCES, INC. | $166.77B | 19.8 |
| PFE | PFIZER INC | $143.91B | 18.6 |
| SYK | STRYKER CORP | $132.87B | 41.3 |
| BMY | BRISTOL MYERS SQUIBB CO | $129.88B | 18.4 |
| ISRG | INTUITIVE SURGICAL INC | $127.82B | 46.0 |
